{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T09:08:17Z","timestamp":1768727297846,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.cct.2011.12.004","type":"journal-article","created":{"date-parts":[[2012,1,13]],"date-time":"2012-01-13T16:20:04Z","timestamp":1326471604000},"page":"606-610","source":"Crossref","is-referenced-by-count":6,"title":["Retention of clinical trial participants in a study of Nongonococcal Urethritis (NGU), a sexually transmitted infection in men"],"prefix":"10.1016","volume":"33","author":[{"given":"Jeannette Y.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelly Y.","family":"Lensing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane R.","family":"Schwebke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cct.2011.12.004_bb0005","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/cid\/ciq074","article-title":"Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens\u2014a randomized clinical trial","volume":"52","author":"Schwebke","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"25","key":"10.1016\/j.cct.2011.12.004_bb0010","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1056\/NEJMcp030542","article-title":"Clinical practice. Genital chlamydial infections","volume":"349","author":"Peipert","year":"2003","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.cct.2011.12.004_bb0015","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1136\/sti.2008.035477","article-title":"Mycoplasma genitalium compared to chlamydia, gonorrhoea and trichomonas as an aetiological agent of urethritis in men attending STD clinics","volume":"85","author":"Gaydos","year":"2009","journal-title":"Sex Transm Infect"},{"issue":"3","key":"10.1016\/j.cct.2011.12.004_bb0020","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/OLQ.0b013e3182040de9","article-title":"Demographic, behavioral, and clinical characteristics of men with nongonococcal urethritis differ by etiology: a case-comparison study","volume":"38","author":"Wetmore","year":"2011","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.cct.2011.12.004_bb0025","unstructured":"Centers for Disease Control and Prevention, Sexually Transmitted Disease Surveillance 2009, U.S. Department of Health and Human Services, Editor 2010: Atlanta, Georgia."},{"issue":"12","key":"10.1016\/j.cct.2011.12.004_bb0030","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/01.olq.0000218865.37084.f6","article-title":"Predicting subsequent infection in patients attending sexually transmitted disease clinics","volume":"33","author":"Newman","year":"2006","journal-title":"Sex Transm Dis"},{"issue":"18","key":"10.1016\/j.cct.2011.12.004_bb0035","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1056\/NEJMsa011565","article-title":"Participation in research and access to experimental treatments by HIV-infected patients","volume":"346","author":"Gifford","year":"2002","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.cct.2011.12.004_bb0040","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/cncr.23201","article-title":"Disparities in participation in cancer clinical trials in the United States: a symptom of a healthcare system in crisis","volume":"112","author":"Colon-Otero","year":"2008","journal-title":"Cancer"},{"issue":"22","key":"10.1016\/j.cct.2011.12.004_bb0045","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1001\/jama.291.22.2720","article-title":"Participation in cancer clinical trials: race-, sex-, and age-based disparities","volume":"291","author":"Murthy","year":"2004","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.cct.2011.12.004_bb0050","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1245\/s10434-007-9500-y","article-title":"Participation in surgical oncology clinical trials: gender-, race\/ethnicity-, and age-based disparities","volume":"14","author":"Stewart","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"36","key":"10.1016\/j.cct.2011.12.004_bb0055","doi-asserted-by":"crossref","first-page":"9282","DOI":"10.1200\/JCO.2005.02.6245","article-title":"Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials","volume":"23","author":"Lara","year":"2005","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.cct.2011.12.004_bb0060","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/cncr.23157","article-title":"Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review","volume":"112","author":"Ford","year":"2008","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.cct.2011.12.004_bb0065","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/13557851003624281","article-title":"Predictors of awareness of clinical trials and feelings about the use of medical information for research in a nationally representative US sample","volume":"15","author":"Brown","year":"2010","journal-title":"Ethn Health"},{"issue":"1","key":"10.1016\/j.cct.2011.12.004_bb0070","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/OLQ.0b013e318148b4ba","article-title":"Do STD clinic patients who consent to sexual health research differ from those who decline? Findings from a randomized controlled trial with implications for the generalization of research results","volume":"35","author":"Carey","year":"2008","journal-title":"Sex Transm Dis"},{"issue":"4","key":"10.1016\/j.cct.2011.12.004_bb0075","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s11904-010-0055-3","article-title":"Increasing and supporting the participation of persons of color living with HIV\/AIDS in AIDS clinical trials","volume":"7","author":"Gwadz","year":"2010","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"2","key":"10.1016\/j.cct.2011.12.004_bb0080","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/01.qai.0000179454.93443.60","article-title":"HIV vaccine trial participation among ethnic minority communities: barriers, motivators, and implications for recruitment","volume":"41","author":"Newman","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"10.1016\/j.cct.2011.12.004_bb0085","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1353\/hpu.2006.0126","article-title":"The Tuskegee Legacy Project: willingness of minorities to participate in biomedical research","volume":"17","author":"Katz","year":"2006","journal-title":"J Health Care Poor Underserved"},{"issue":"1","key":"10.1016\/j.cct.2011.12.004_bb0090","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/AOG.0b013e318220ebf3","article-title":"Disparities in human papillomavirus vaccine completion among vaccine initiators","volume":"118","author":"Chou","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cct.2011.12.004_bb0095","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2288-9-19","article-title":"Determinants of subject visit participation in a prospective cohort study of HTLV infection","volume":"9","author":"DeVita","year":"2009","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"10.1016\/j.cct.2011.12.004_bb0100","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/1740774509105224","article-title":"Retention of under-represented minorities in drug abuse treatment studies","volume":"6","author":"Magruder","year":"2009","journal-title":"Clin Trials"},{"key":"10.1016\/j.cct.2011.12.004_bb0105","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1745-6215-10-40","article-title":"LOST to follow-up Information in Trials (LOST-IT): a protocol on the potential impact","volume":"10","author":"Akl","year":"2009","journal-title":"Trials"},{"issue":"5","key":"10.1016\/j.cct.2011.12.004_bb0110","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/sti.2010.048553","article-title":"Effect of gatifloxacin against mycoplasma genitalium-related urethritis: an open clinical trial","volume":"87","author":"Hamasuna","year":"2011","journal-title":"Sex Transm Infect"},{"issue":"8","key":"10.1016\/j.cct.2011.12.004_bb0115","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/01.olq.0000253348.44308.8c","article-title":"A randomized, double-blind study comparing single-dose rifalazil with single-dose azithromycin for the empirical treatment of nongonococcal urethritis in men","volume":"34","author":"Stamm","year":"2007","journal-title":"Sex Transm Dis"},{"issue":"12","key":"10.1016\/j.cct.2011.12.004_bb0120","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1086\/599033","article-title":"A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men","volume":"48","author":"Mena","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.cct.2011.12.004_bb0125","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa041681","article-title":"Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection","volume":"352","author":"Golden","year":"2005","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.cct.2011.12.004_bb0130","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1097\/AOG.0b013e318177143a","article-title":"Preventing recurrent sexually transmitted diseases in minority adolescents: a randomized controlled trial","volume":"111","author":"Thurman","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.cct.2011.12.004_bb0135","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.cct.2011.03.008","article-title":"What predicts non-retention in microbicide trials?","volume":"32","author":"Feldblum","year":"2011","journal-title":"Contemp Clin Trials"},{"issue":"12","key":"10.1016\/j.cct.2011.12.004_bb0140","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1001\/archinte.168.12.1294","article-title":"Why patients continue to participate in clinical research","volume":"168","author":"Wendler","year":"2008","journal-title":"Arch Intern Med"},{"issue":"10","key":"10.1016\/j.cct.2011.12.004_bb0145","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1089\/jwh.2008.1337","article-title":"Retention and attendance of women enrolled in a large prospective study of HIV-1 in the United States","volume":"18","author":"Hessol","year":"2009","journal-title":"J Womens Health (Larchmt)"},{"issue":"4","key":"10.1016\/j.cct.2011.12.004_bb0150","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/01.qai.0000148532.12329.df","article-title":"Participant retention in clinical trials of candidate HIV vaccines","volume":"39","author":"de Bruyn","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"10.1016\/j.cct.2011.12.004_bb0155","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cct.2009.12.004","article-title":"Recruitment, enrollment and retention of young black men for HIV prevention research: experiences from The 411 for Safe Text project","volume":"31","author":"Fortune","year":"2010","journal-title":"Contemp Clin Trials"},{"issue":"8","key":"10.1016\/j.cct.2011.12.004_bb0160","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1089\/aid.2009.0282","article-title":"Enrollment, retention, and visit attendance in the University of North Carolina Center for AIDS Research HIV clinical cohort, 2001-2007","volume":"26","author":"Howe","year":"2010","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"3","key":"10.1016\/j.cct.2011.12.004_bb0165","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ygyno.2011.02.007","article-title":"Recruitment and retention results for a population-based cervical cancer biobehavioral clinical trial","volume":"121","author":"Osann","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"5996","key":"10.1016\/j.cct.2011.12.004_bb0170","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":"Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women","volume":"329","author":"Abdool","year":"2010","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.cct.2011.12.004_bb0175","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/QAD.0b013e32834541d9","article-title":"Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women","volume":"25","author":"Abdool","year":"2011","journal-title":"AIDS"},{"issue":"Suppl. 3","key":"10.1016\/j.cct.2011.12.004_bb0180","doi-asserted-by":"crossref","first-page":"iii45","DOI":"10.1136\/sti.2010.042283","article-title":"The concentration of sexual behaviours in the USA: a closer examination of subpopulations","volume":"86","author":"Leichliter","year":"2010","journal-title":"Sex Transm Infect"},{"issue":"11","key":"10.1016\/j.cct.2011.12.004_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.1000368","article-title":"Strategies for increasing recruitment to randomised controlled trials: systematic review","volume":"7","author":"Caldwell","year":"2010","journal-title":"PLoS Med"},{"issue":"3","key":"10.1016\/j.cct.2011.12.004_bb0190","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.qai.0000152039.88422.ec","article-title":"Motivations for participating in an HIV vaccine efficacy trial","volume":"39","author":"Colfax","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"10.1016\/j.cct.2011.12.004_bb0195","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0376-8716(03)00074-7","article-title":"A randomized controlled trial of monetary incentives vs. outreach to enhance adherence to the hepatitis B vaccine series among injection drug users","volume":"71","author":"Seal","year":"2003","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.cct.2011.12.004_bb0200","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/sti.74.4.253","article-title":"What about money? Effect of small monetary incentives on enrollment, retention, and motivation to change behaviour in an HIV\/STD prevention counselling intervention. The Project RESPECT Study Group","volume":"74","author":"Kamb","year":"1998","journal-title":"Sex Transm Infect"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714412000225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714412000225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T18:28:32Z","timestamp":1593541712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714412000225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S1551714412000225"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2011.12.004","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}